PANEL CHAIRS |
PERSONAL FINANCIAL RELATIONSHIP |
INSTITUTIONAL RESEARCH |
UPDATED DATE |
Raymond T. Chung, MD |
None |
Dr Chung was awarded research grants, paid to his institution, from AbbVie, Bristol-Myers Squibb, Gilead Sciences, Inc, Janssen Therapeutics, Inc, MassBiologics, and Merck & Co, Inc. |
10/21/15 |
Arthur Y. Kim, MD |
Dr Kim served on the advisory boards of AbbVie (ceased as of March 2014) and Bristol-Myers Squibb (ceased as of July 2014). |
Dr Kim was awarded research grants, paid to his institution, from AbbVie, Bristol-Myers Squibb, and Gilead Sciences, Inc. |
11/20/15 |
Susanna Naggie, MD |
Dr Naggie served on an advisory board for Merck & Co, Inc (ceased as of September 2015). |
Dr Naggie was awarded research grants, paid to her institution, from AbbVie, Benitec Biopharma, Bristol-Myers Squibb, Gilead Sciences, Inc, Janssen Therapeutics, Inc, Merck & Co, Inc, and Vertex Pharmaceuticals. |
11/16/15 |
Hugo E. Vargas, MD |
None |
Dr Vargas was awarded research grants, paid to his institution, from AbbVie, Gilead Sciences, Inc, and Mercks & Co, Inc. |
09/29/15 |
PANEL MEMBERS |
PERSONAL FINANCIAL RELATIONSHIP |
INSTITUTIONAL RESEARCH |
UPDATED DATE |
Andrew I. Aronsohn, MD |
None |
None |
09/28/15 |
Debika Bhattacharya, MD |
None |
Dr Bhattacharya received study drugs, given to her institution, for research trials from AbbVie, Bristol-Myers Squibb, and Merck & Co, Inc. |
10/20/15 |
Michael R. Charlton, MD |
Dr Charlton serves on the advisory boards of or as a consultant to AbbVie, Gilead Sciences, Inc, and Janssen Therapeutics, Inc. |
Dr Charlton was awarded research grants, paid to his institution, from Gilead Sciences, Inc, and Novartis International AG. |
09/28/15 |
Robert J. Fontana, MD |
Dr Fontana served on a data and safety monitoring board for Tibotec Therapeutics. He serves as a consultant to Bristol-Myers Squibb. |
Dr Fontana was awarded research grants, paid to his institution, from Bristol-Myers Squibb, Gilead Sciences, Inc, Janssen Therapeutics, Inc, and Vertex Pharmaceuticals, Inc. |
09/30/15 |
Eliot W. Godofsky, MD |
Dr Godofsky serves on the advisory boards of AbbVie, and Janssen Therapeutics, Inc. |
Dr Godofsky was awarded research grants, paid to his practice, from AbbVie, Achillion, Anadys, Boehringer Ingelheim Pharmaceuticals, Inc, Genentech, Gilead Sciences, Inc, Janssen Therapeutics, Inc, Merck & Co, Inc, Norvartis, and Vertex Pharmaceuticals, Inc. |
09/28/15 |
Theo Heller, MD |
None |
None |
10/20/15 |
Scott D. Holmberg, MD |
None |
None |
10/20/15 |
Jennifer J. Kiser, PharmD |
None |
Dr Kiser was awarded research grants, paid to her institution, from Janssen Therapeutics, Inc, and ViiV Healthcare. |
09/28/15 |
Shyam Kottilil, MD, PhD |
None |
None |
09/28/15 |
Benjamin P. Linas, MD, MPH |
None |
None |
10/08/15 |
Kristen Marks, MD |
None |
Dr Marks was awarded research grants, paid to her institution, from Gilead Sciences, Inc, and Merks & Co, Inc. |
10/09/15 |
Paul Martin, MD |
Dr Martin serves on an advisory board for Bristol-Myers Squibb. |
Dr Martin was awarded research grants, paid to his institution, from AbbVie, Gilead Sciences, Inc, and Merck & Co, Inc. |
09/29/15 |
Timothy R. Morgan, MD |
None |
Dr Morgan was awarded research grants, paid to his institution, from AbbVie, Bristol-Myers Squibb, Genentech, Gilead Sciences, Inc, Merck & Co, Inc, and Roche. |
09/30/15 |
Ronald G. Nahass, MD, MHCM, FACP, FIDSA |
Dr Nahass serves on advisory boards for Bristol-Myers Squibb, Gilead Sciences, Inc, Janssen Therapeutics, Inc, and Merck & Co, Inc. He also participates on speakers bureaus for and received honoraria from Bristol-Myers Squibb, Gilead Science, Inc, Janssen Therapeutics, Inc, and Merck & Co, Inc. |
Dr Nahass was awarded research grants, paid to his institution, from Gilead Sciences, Inc, Janssen Therapeutics, Inc, and Merck & Co, Inc. |
10/20/15 |
Oluwaseun O. Falade-Nwulia, MBBS, MPH |
None |
Dr Falade-Nwulia’s was awarded research grants, paid to her institution, from Gilead Sciences, Inc. |
10/20/15 |
Marion G. Peters, MD |
Dr Peters serves on the advisory boards of Gilead Sciences, Inc, Janssen Therapeutics, Inc, and Merck & Co, Inc. |
None |
10/11/15 |
Daniel Raymond |
None |
Mr Raymond’s organization was awarded educational grants from Genentech, Gilead Sciences, Inc, and Janssen Therapeutics, Inc. |
01/14/15 |
Nancy Reau, MD |
Dr Reau serves on the advisory boards of AbbVie, Bristol-Myers Squibb, Gilead Sciences, Inc, Janssen Therapeutics, Inc, and Merck & Co, Inc. She has served as a consultant for Accordant. |
Dr Reau was awarded research grants, paid to her institution, from Abbott Laboratories, Bristol-Myers Squibb, Gilead Sciences, Inc, and Hyperion Therapeutics, Inc. |
10/10/15 |
K. Rajender Reddy, MD |
Dr Reddy serves on advisory boards for AbbVie, Bristol-Myers Squibb, Genentech, Gilead Sciences, Inc, Janssen Therapeutics, Inc, Merck & Co, Inc, and Vertex Pharmaceuticals, Inc. He also receives royalties from UpToDate, Inc. |
Dr Reddy was awarded research grants, paid to his institution, from AbbVie, Bristol-Myers Squibb, GENFIT Corp, Gilead Sciences, Inc, Janssen Therapeutics, Inc, and Vertex Pharmaceuticals, Inc. |
10/11/15 |
Andrew Reynolds |
None |
Mr Reynolds’s organization was awarded educational grants from AbbVie, Amgen, Bio-Rad Bristol-Myers Squibb, Genentech, Gilead Sciences, Inc, Janssen Therapeutics, Inc, Mercks & Co, Inc, OraSure Technologies, Inc, Roche, and Walgreens Co. |
10/14/15 |
Michael S. Saag, MD |
None |
Dr Saag was awarded research grants, paid to his institution, from Abbvie, Bristol-Myers Squibb, Gilead Sciences, Inc, Janssen Therapeutics, Inc, Merck & Co, Inc, and ViiV Healthcare. |
05/04/15 |
John D. Scott, MD, MSc, FIDSA |
Dr Scott serves on a data and safety monitoring board for Tacere Therapeutics. He also serves as a consultant to Bristol-Myers Squibb, and Gilead Sciences, Inc. |
Dr Scott was awarded research grants from Merck & Co, Inc |
10/20/15 |
Tracy Swan |
None |
Ms Swan’s organization was awarded educational grants from Bristol-Myers Squibb, Boehringer Ingelheim Pharmaceuticals, Genentech, Gilead Sciences, Inc, Janssen Therapeutics, Inc, Mercks & Co, Inc, and ViiV Healthcare. |
09/29/15 |
Norah A. Terrault, MD |
Dr Terrault serves on the advisory boards of AbbVie (uncompensated), Bristol-Myers Squibb, Gilead Sciences, Inc, (uncompensated), Merck & Co, Inc, and Pfizer She also serves as a consultant to Clinical Care Options, LLC, and UpToDate, Inc. |
Dr Terrault was awarded research grants, paid to her institution, from AbbVie, Biotest AG, Gilead Sciences, Inc, Novartis International AG, and Vertex Pharmaceuticals, Inc. |
10/11/15 |
John B. Wong, MD |
None |
None |
01/20/15 |
David L. Wyles, MD |
Dr Wyles serves on the advisory board of AbbVie, Bristol-Myers Squibb, Gilead Sciences, Inc, and Janssen Therapeutics, Inc. |
Dr Wyles was awarded research grants, paid to his institution, from AbbVie, Bristol-Myers Squibb, Gilead Sciences, Inc, Merck & Co, Inc, Tacere Therapeutics, and Vertex Pharmaceuticals, Inc. |
10/08/15 |